Patients with AML must be evaluated to determine whether they harbor high-risk factors for drug resistance, as we suggested in this study FLT3-ITD and overexpression of acid ceramidase could be considered as adverse factors that lead to autophagy and chemo-resistance in these patients. Here, FLT3 is linked to acute myeloid leukemia.